| Cardiac arrest after intravenous injection of cimetidine. | |
| | |
MedLine Citation:
|
PMID: 7464625 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Three episodes, in which patients suffered a cardiac arrest in close association with receiving a bolus intravenous injection of cimetidine, are reported. The possible role of cimetidine in causing cardiac arrest, and the mechanisms which may be involved, are discussed. It is recommended that intravenous administration of cimetidine should be an infusion performed over at least 30 minutes. |
| | |
Authors:
|
R G Shaw; M L Mashford; P V Desmond |
Related Documents
:
|
7498015 - Priapism: a historical and update review. 17379115 - Neonatal foal resuscitation. 993875 - Toxicology of petroleum naphtha distillate vapors. 2555035 - Fatal angioedema associated with enalapril. 10467205 - Bedside markers of coronary artery patency and short-term prognosis of patients with ac... 22254195 - Chads(2) score is predictive of left atrial thrombus on precardioversion transesophagea... |
Publication Detail:
|
Type: Case Reports; Journal Article |
Journal Detail:
|
Title: The Medical journal of Australia Volume: 2 ISSN: 0025-729X ISO Abbreviation: Med. J. Aust. Publication Date: 1980 Nov |
Date Detail:
|
Created Date: 1981-04-24 Completed Date: 1981-04-24 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 0400714 Medline TA: Med J Aust Country: AUSTRALIA |
Other Details:
|
Languages: eng Pagination: 629-30 Citation Subset: IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Cimetidine / administration & dosage, adverse effects* Female Guanidines / adverse effects* Heart Arrest / chemically induced* Humans Injections, Intravenous Male Middle Aged |
| Chemical | |
Reg. No./Substance:
|
0/Guanidines; 51481-61-9/Cimetidine |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Sigmoidoscopic reduction of sigmoid volvulus.
Next Document: Driving behavior of cardiovascular patients as affected by beta receptor blockers